Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial

Stanley B. Cohen, Robin K. Dore, Nancy E. Lane, Peter A. Ory, Charles G. Peterfy, John T. Sharp, Désirée Van Der Heijde, Lifen Zhou, Wayne Tsuji, Richard Newmark

Research output: Contribution to journalArticlepeer-review

434 Scopus citations

Fingerprint

Dive into the research topics of 'Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences